Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06323291 · ClinicalTrials.gov registry record · Early Phase 1

Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study

A Early Phase 1 study of Pancreatic Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
Early Phase 1
Development phase
20
Enrollment target
1
Study location

NCT06323291: Completed Early Phase 1 study of Pancreatic Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT06323291 is a Early Phase 1 study of Pancreatic Cancer that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 20 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06323291, a Early Phase 1 study of Pancreatic Cancer, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
Early Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This Pilot Study will evaluate a 12-week pilot program that offers digital health coaching for individuals with pancreatic cancer and their caregivers.

Primary Outcome

Measured by ≥ 50% of eligible participants recruited.

Conditions Studied

Pancreatic Cancer

Interventions

  • BEHAVIORAL Coaching Sessions

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-04-01
Est. Completion 2025-05-26
Phase Early Phase 1
H. Lee Moffitt Cancer Center and Research Institute

502 total trials

What the finished NCT06323291 record still lists

NCT06323291 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Coaching Sessions is the first listed.

NCT06323291 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06323291 about?

NCT06323291 is a clinical study titled "Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study". This Pilot Study will evaluate a 12-week pilot program that offers digital health coaching for individuals with pancreatic cancer and their caregivers.

What is the current status of trial NCT06323291?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2024-04-01. Estimated completion is 2025-05-26.

What conditions does trial NCT06323291 study?

This clinical trial studies the following conditions: Pancreatic Cancer.

What interventions are being tested in trial NCT06323291?

The interventions under investigation include: Coaching Sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06323291?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06323291 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pancreatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06323291's enrollment target sits among peer trials

20 225th of 278 higher than 47 of 278 other Pancreatic Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pancreatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06323291, the US trial registry maintained by the National Library of Medicine. NCT06323291 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.